ClearPoint Neuro, Inc. CLPT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 34.20% | -18.69% | -22.68% | -32.17% | -0.93% |
| Total Depreciation and Amortization | 23.14% | 31.86% | 8.51% | 76.53% | -31.95% |
| Total Amortization of Deferred Charges | 2.00% | 3.24% | 177.87% | 212.82% | 85.71% |
| Total Other Non-Cash Items | -33.31% | 4.76% | 20.20% | -5.85% | -4.14% |
| Change in Net Operating Assets | -1,070.49% | 105.50% | 69.91% | -20,960.00% | -117.77% |
| Cash from Operations | 27.13% | 11.95% | 34.05% | -287.06% | -22.30% |
| Capital Expenditure | 35.98% | 66.82% | -1,216.33% | 75.38% | -118.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 35.98% | 66.82% | -159.28% | 646.73% | -118.68% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,104.90% | 576.35% | -54.60% | -- | -100.00% |
| Repurchase of Common Stock | -- | 100.00% | -922.05% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,104.90% | 154.25% | -109.43% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 370.10% | 40.44% | -221.99% | 358.19% | -111.32% |